Daina Graybosch

Daina Graybosch has extensive work experience in the field of biotechnology analysis and consulting. Daina is currently serving as the Senior Managing Director and Biotechnology Analyst, specializing in Immuno-Oncology, at Leerink Partners since February 2022. Prior to this, Daina held the role of Managing Director, Senior Biotechnology Analyst, specializing in Immuno-Oncology, at SVB Leerink LLC from June 2018 to February 2022. Before transitioning to the investment banking sector, they worked at McKinsey & Company from January 2007 to June 2018, where they held various senior positions, including Senior Expert, Associate Principal, Engagement Manager, and Associate.

Daina Graybosch completed their education with a Ph.D. in Structural Biology and Biochemistry from Harvard University, which they obtained between the years 2001 and 2006. Prior to that, they acquired a Bachelor of Science degree in Organismal and Evolutionary Biology, with a minor in Chemistry, from the University of Utah. This undergraduate degree was earned during the period of 1996 to 2001.